Ranbaxy Laboratories gets USFDA nod for Acetaminophen

16 Dec 2011 Evaluate

Ranbaxy Laboratories has received US Food and Drug Administration (USFDA) approval to sell its generic drug acetaminophen in the world’s largest drug market. Acetaminophen is used for relief of headaches and other minor aches and pains.

Recently, Ranbaxy Laboratories had managed to capture about 2.5% market share in the generic Lipitor segment during initial days of its launch in the US.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×